Anvisa To Access US FDA-Reviewed Data For More Robust Evaluations In Brazil

 
• By Francesca Bruce
Brazil And Us Flaggs
US AND Brazilian agencies agree to swap information

More from Pink Sheet

More from Pathways & Standards